论文信息 - Disease-modifying antirheumatic drugs - 字舞流文

Disease-modifying antirheumatic drugs

David G. Lambert | D. Lambert

[1] P. Tugwell,et al. Meta-analysis of treatment termination rates among rheumatoid arthritis patients receiving disease-modifying anti-rheumatic drugs. , 2000, Rheumatology.

[2] J. Smolen,et al. Therapeutic strategies for rheumatoid arthritis , 2003, Nature Reviews Drug Discovery.

[3] P Barton,et al. The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis. , 2004, Health technology assessment.

[4] D J Rowlands,et al. A multi-centre randomised controlled trial of minimally invasive direct coronary bypass grafting versus percutaneous transluminal coronary angioplasty with stenting for proximal stenosis of the left anterior descending coronary artery. , 2004, Health technology assessment.

[5] B. Rothschild. Review: individual DMARDs have similar efficacy for RA, but combination therapy improves response , 2008, Evidence-based medicine.

[6] Zoe Stableford,et al. Guidelines British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis ( after the first 2 years ) , 2009 .